A Study of Efficacy and Safety of Ianalumab in Previously Treated Patients With Warm Autoimmune Hemolytic Anemia
Clinical trial NCT05648968 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05648968
- Sponsor
- Novartis Pharmaceuticals
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-30
- Primary completion
- 2026-02-20
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.